Beghin D
Centre de référence sur les agents tératogènes (CRAT), DMU ESPRIT (épidémiologie et biostatistique, santé publique, pharmacie, pharmacologie, recherche, information médicale, thérapeutique et médicaments), GHU AP-HP Sorbonne université, site Trousseau 26, avenue Dr Netter, 75571 Paris cedex 12, France.
Gynecol Obstet Fertil Senol. 2022 May;50(5):422-425. doi: 10.1016/j.gofs.2022.02.076. Epub 2022 Feb 24.
Physiological changes that occur during pregnancy in the maternal body can lead to alterations in the response to drugs in the mother. Pregnancy modifies the volume of distribution of drugs, their binding to plasma proteins, the activity of their metabolizing enzymes, and their elimination. However, to date, due to the dynamic and complex processes involved, adjustments to the dosage regimen during pregnancy remain impossible to standardize. Knowledge of these modifications will help to better understand the possible loss of drug efficacy during pregnancy, as well as anticipating the clinical and plasma monitoring of drugs with a low therapeutic margin.
孕期母体发生的生理变化会导致母亲对药物的反应发生改变。怀孕会改变药物的分布容积、与血浆蛋白的结合、代谢酶的活性及其消除。然而,迄今为止,由于涉及动态和复杂的过程,孕期给药方案的调整仍无法标准化。了解这些变化将有助于更好地理解孕期药物疗效可能丧失的情况,以及预测治疗窗较窄药物的临床和血浆监测。